INOPASE logo — Exploring a new way of treating chronic diseases through per...

INOPASE

Exploring a new way of treating chronic diseases through personalized closed-loop neuromodulation

Founded 2021 Japan Japan 9 employees Non Equity Assistance Health Care, IT +2

General Information

Company Name INOPASE
Founded Year 2021
Location Japan Japan
Employees 9
Industries Health Care, IT, Manufacturing +1
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with INOPASE. To contact INOPASE, visit inopase.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does INOPASE compare?

A PDF of INOPASE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting INOPASE soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About INOPASE

INOPASE is an innovative medical device company, founded in 2021, with the mission of providing advanced solutions for chronic neurological diseases. The company's slogan, "Exploring a new way of treating chronic diseases through personalized closed-loop neuromodulation," reflects its commitment to pioneering personalized, wireless-powered closed-loop neuromodulation technology. This approach not only allows patients to effectively manage their symptoms but also enhances their overall quality of life. INOPASE operates at the intersection of Health Care, IT, Manufacturing, and Medical Devices, leveraging cutting-edge technologies to address the unique needs of patients with chronic neurological conditions. With its headquarters in Japan, the company has assembled a team of experienced professionals dedicated to the development and delivery of high-quality medical devices. As of now, there is no publicly available information regarding the last investment received by INOPASE or the involved investors. However, the company's focus on personalized, innovative medical solutions positions it at the forefront of addressing unmet needs in the treatment of chronic diseases, making it an intriguing prospect for potential venture capital investment.

No funding data available for INOPASE yet.

INOPASE Alternatives & Competitors

View All Alternatives
INOPASE vs

Innovative neurostimulation therapies empowering neurological health since 2007.

Non Equity Assistance
51-200 employees
Health Care, Manufacturing
INOPASE vs
Hylomorph
Hylomorph Switzerland

pioneering innovation in preventive medicine

Series B
12 employees
Health Care, Medical Devices
INOPASE vs

Our vision is to end preventable blindness using innovative devices, AI, digital platform and last m...

Series B
218 employees
Health Care, Medical Devices

FAQ About INOPASE

Exploring a new way of treating chronic diseases through personalized closed-loop neuromodulation
INOPASE was founded in 2021.
INOPASE is headquartered in Japan.
INOPASE operates in Health Care, IT, Manufacturing and Medical Devices.
INOPASE has approximately 9 employees.
Top alternatives and competitors to INOPASE include MicroTransponder, Hylomorph, Forus Health, Tesla Medical s.r.o., Dawn Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
INOPASE and MicroTransponder are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for INOPASE, https://bouncewatch.com/company/inopase, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes